Cell rigidity and shape override CD47's "self"-signaling in phagocytosis by hyperactivating myosin-II

Blood

Volumn 125, Issue 3, 2015, Pages 542-552

  Sosale, Nisha G ^a   Rouhiparkouhi, Tahereh ^b   Bradshaw, Andrew M ^a   Dimova, Rumiana ^b   Lipowsky, Reinhard ^b   Discher, Dennis E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN; MYOSIN II; DIFFERENTIATION ANTIGEN; IMMUNOGLOBULIN RECEPTOR; MYOSIN IIA; SIRPA PROTEIN, HUMAN;

ANEMIA; ARTICLE; BLOOD STORAGE; DISCOCYTE; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE SHAPE; ERYTHROPOIESIS; HUMAN; HUMAN CELL; MACROPHAGE; MALARIA; NEOPLASM; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENESCENCE; SICKLE CELL; STOMATOCYTE; CELL COMMUNICATION; CELL CULTURE; CELL JUNCTION; CELL SHAPE; CYTOLOGY; FLOW CYTOMETRY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ANTIGENS, CD47; ANTIGENS, DIFFERENTIATION; CELL COMMUNICATION; CELL SHAPE; CELLS, CULTURED; ERYTHROCYTES; FLOW CYTOMETRY; HUMANS; INTERCELLULAR JUNCTIONS; NONMUSCLE MYOSIN TYPE IIA; PHAGOCYTOSIS; PHOSPHORYLATION; RECEPTORS, IMMUNOLOGIC;

EID: 84922424757     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-06-585299     Document Type: Article

References (78)

1. Ravetch JV, Lanier LL. Immune inhibitory receptors. Science. 2000;290(5489):84-89.
2. Vicente-Manzanares M, Sánchez-Madrid F. Role of the cytoskeleton during leukocyte responses. Nat Rev Immunol. 2004;4(2):110-122.
3. Swanson JA. Shaping cups into phagosomes and macropinosomes. Nat Rev Mol Cell Biol. 2008;9(8):639-649.
4. Flannagan RS, Jaumouillé V, Grinstein S. The cell biology of phagocytosis. Annu Rev Pathol. 2012;7:61-98.
5. Olazabal IM, Caron E, May RC, Schilling K, Knecht DA, Machesky LM. Rho-kinase and myosin-II control phagocytic cup formation during CR, but not FcgammaR, phagocytosis. Curr Biol. 2002;12(16):1413-1418.
6. Araki N, Hatae T, Furukawa A, Swanson JA. Phosphoinositide-3-kinase-independent contractile activities associated with Fcgamma-receptor-mediated phagocytosis and macropinocytosis in macrophages. J Cell Sci. 2003;116(Pt 2):247-257.
7. Tsai RK, Discher DE. Inhibition of "self" engulfment through deactivation of myosin-II at the phagocytic synapse between human cells. J Cell Biol. 2008;180(5):989-1003.
8. Jiang P, Lagenaur CF, Narayanan V. Integrin-associated protein is a ligand for the P84 neural adhesion molecule. J Biol Chem. 1999;274(2):559-562.
9. Veillette A, Thibaudeau E, Latour S. High expression of inhibitory receptor SHPS-1 and its association with protein-tyrosine phosphatase SHP-1 in macrophages. J Biol Chem. 1998;273(35):22719-22728.
10. Okazawa H, Motegi S, Ohyama N, et al. Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system. J Immunol. 2005;174(4):2004-2011.
11. Baba T, Fusaki N, Shinya N, Iwamatsu A, Hozumi N. Myosin is an in vivo substrate of the protein tyrosine phosphatase (SHP-1) after mIgM cross-linking. Biochem Biophys Res Commun. 2003;304(1):67-72.
12. Rodriguez PL, Harada T, Christian DA, Pantano DA, Tsai RK, Discher DE. Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science. 2013;339(6122):971-975.
13. Oldenborg PA, Gresham HD, Lindberg FP. CD47-signal regulatory protein a (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis. J Exp Med. 2001;193(7):855-862.
14. Gardai SJ, McPhillips KA, Frasch SC, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell. 2005;123(2):321-334.
15. Blazar BR, Lindberg FP, Ingulli E, et al. CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells. J Exp Med. 2001;194(4):541-549.
16. Jaiswal S, Jamieson CH, Pang WW, et al. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 2009;138(2):271-285.
17. Weiskopf K, Ring AM, Ho CC, et al. Engineered SIRPa variants as immunotherapeutic adjuvants to anticancer antibodies. Science. 2013;341(6141):88-91.
18. Kay MM. Mechanism of removal of senescent cells by human macrophages in situ. Proc Natl Acad Sci USA. 1975;72(9):3521-3525.
19. Turrini F, Arese P, Yuan J, Low PS. Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis. J Biol Chem. 1991;266(35):23611-23617.
20. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. Role of CD47 as a marker of self on red blood cells. Science. 2000;288(5473):2051-2054.
21. Lutz HU. Innate immune and non-immune mediators of erythrocyte clearance. Cell Mol Biol (Noisy-le-grand). 2004;50(2):107-116.
22. Bosman GJ, Werre JM, Willekens FL, Novotný VM. Erythrocyte ageing in vivo and in vitro: structural aspects and implications for transfusion. Transfus Med. 2008;18(6):335-347.
23. Hod EA, Zhang N, Sokol SA, et al. Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation. Blood. 2010;115(21):4284-4292.
24. Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood. 2008;112(10):3939-3948.
25. Reliene R, Mariani M, Zanella A, et al. Splenectomy prolongs in vivo survival of erythrocytes differently in spectrin/ankyrin- and band 3-deficient hereditary spherocytosis. Blood. 2002;100(6):2208-2215.
26. Chasis JA, Mohandas N. Erythrocyte membrane deformability and stability: two distinct membrane properties that are independently regulated by skeletal protein associations. J Cell Biol. 1986;103(2):343-350.
27. Mohandas N, Evans E. Mechanical properties of the red cell membrane in relation to molecular structure and genetic defects. Annu Rev Biophys Biomol Struct. 1994;23:787-818.
28. Raat NJ, Ince C. Oxygenating the microcirculation: the perspective from blood transfusion and blood storage. Vox Sang. 2007;93(1):12-18.
29. Giarratana MC, Marie T, Darghouth D, Douay L. Biological validation of bio-engineered red blood cell productions. Blood Cells Mol Dis. 2013;50(2):69-79.
30. Leblond PF, Lacelle PL, Weed RI. Cellular deformability: a possible determinant of the normal release of maturing erythrocytes from the bone marrow. Blood. 1971;37(1):40-46.
31. Chasis JA, Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood. 2008;112(3):470-478.
32. Bercoff J, Chaffai S, Tanter M, et al. In vivo breast tumor detection using transient elastography. Ultrasound Med Biol. 2003;29(10):1387-1396.
33. Lam WA, Rosenbluth MJ, Fletcher DA. Chemotherapy exposure increases leukemia cell stiffness. Blood. 2007;109(8):3505-3508.
34. Cross SE, Jin YS, Rao J, Gimzewski JK. Nanomechanical analysis of cells from cancer patients. Nat Nanotechnol. 2007;2(12):780-783.
35. Beningo KA, Wang YL. Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J Cell Sci. 2002;115(Pt 4):849-856.
36. Jain SK, Mohandas N, Clark MR, Shohet SB. The effect of malonyldialdehyde, a product of lipid peroxidation, on the deformability, dehydration and 51Cr-survival of erythrocytes. Br J Haematol. 1983;53(2):247-255.
37. Hebbel RP, Miller WJ. Phagocytosis of sickle erythrocytes: immunologic and oxidative determinants of hemolytic anemia. Blood. 1984;64(3):733-741.
38. Salem M, Mauguen Y, Prangé T. Revisiting glutaraldehyde cross-linking: the case of the Arg-Lys intermolecular doublet. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010;66(Pt 3):225-228.
39. Ballas SK, Mohandas N. Pathophysiology of vaso-occlusion. Hematol Oncol Clin North Am. 1996;10(6):1221-1239.
40. Tsai M, Kita A, Leach J, et al. In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J Clin Invest. 2012;122(1):408-418.
41. Deplaine G, Safeukui I, Jeddi F, et al. The sensing of poorly deformable red blood cells by the human spleen can be mimicked in vitro. Blood. 2011;117(8):88-95.
42. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5(8):606-616.
43. Merkel TJ, Jones SW, Herlihy KP, et al. Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc Natl Acad Sci USA. 2011;108(2):586-591.
44. Shin JW, Buxboim A, Spinler KR, et al. Contractile forces sustain and polarize hematopoiesis from stem and progenitor cells. Cell Stem Cell. 2014;14(1):81-93.
45. Féréol S, Fodil R, Labat B, et al. Sensitivity of alveolar macrophages to substrate mechanical and adhesive properties. Cell Motil Cytoskeleton. 2006;63(6):321-340.
46. Oakes PW, Patel DC, Morin NA, et al. Neutrophil morphology and migration are affected by substrate elasticity. Blood. 2009;114(7):1387-1395.
47. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126(4):677-689.
48. Hod EA, Brittenham GM, Billote GB, et al. Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood. 2011;118(25):6675-6682.
49. Rutala WA, Weber DJ, Healthcare Infection Control Practices Advisory Committee. Guideline for disinfection and sterilization in healthcare facilities. Available at: http://www.cdc.gov/hicpac/pdf/guidelines/disinfection-nov-2008.pdf. Accessed November 28, 2014.
50. Di Stefano F, Siriruttanapruk S, McCoach J, Burge PS. Glutaraldehyde: an occupational hazard in the hospital setting. Allergy. 1999;54(10):1105-1109.
51. Li J, Dao M, Lim CT, Suresh S. Spectrin-level modeling of the cytoskeleton and optical tweezers stretching of the erythrocyte. Biophys J. 2005;88(5):3707-3719.
52. Lo CM, Buxton DB, Chua GC, Dembo M, Adelstein RS, Wang YL. Nonmuscle myosin IIb is involved in the guidance of fibroblast migration. Mol Biol Cell. 2004;15(3):982-989.
53. Raab M, Swift J, Dingal PC, Shah P, Shin JW, Discher DE. Crawling from soft to stiff matrix polarizes the cytoskeleton and phosphoregulates myosin-II heavy chain. J Cell Biol. 2012;199(4):669-683.
54. Patel NR, Bole M, Chen C, et al. Cell elasticity determines macrophage function. PLoS ONE. 2012;7(9):e41024.
55. Blakney AK, Swartzlander MD, Bryant SJ. The effects of substrate stiffness on the in vitro activation of macrophages and in vivo host response to poly(ethylene glycol)-based hydrogels. J Biomed Mater Res A. 2012;100(6):1375-1386.
56. Lammel U, Bechtold M, Risse B, et al. The Drosophila FHOD1-like formin Knittrig acts through Rok to promote stress fiber formation and directed macrophage migration during the cellular immune response. Development. 2014;141(6):1366-1380.
57. Tanner K, Boudreau A, Bissell MJ, Kumar S. Dissecting regional variations in stress fiber mechanics in living cells with laser nanosurgery. Biophys J. 2010;99(9):2775-2783.
58. Sen S, Tewari M, Zajac A, Barton E, Sweeney HL, Discher DE. Upregulation of paxillin and focal adhesion signaling follows Dystroglycan Complex deletions and promotes a hypertensive state of differentiation. Eur J Cell Biol. 2011;90(2-3):249-260.
59. Christian JA, Rebar AH, Boon GD, Low PS. Senescence of canine biotinylated erythrocytes: increased autologous immunoglobulin binding occurs on erythrocytes aged in vivo for 104 to 110 days. Blood. 1993;82(11):3469-3473.
60. Rettig MP, Low PS, Gimm JA, Mohandas N, Wang J, Christian JA. Evaluation of biochemical changes during in vivo erythrocyte senescence in the dog. Blood. 1999;93(1):376-384.
61. Franco RS, Puchulu-Campanella ME, Barber LA, et al. Changes in the properties of normal human red blood cells during in vivo aging. Am J Hematol. 2013;88(1):44-51.
62. Tada K, Tanaka M, Hanayama R, et al. Tethering of apoptotic cells to phagocytes through binding of CD47 to Src homology 2 domain-bearing protein tyrosine phosphatase substrate-1. J Immunol. 2003;171(11):5718-5726.
63. Da Costa L, Galimand J, Fenneteau O, Mohandas N. Hereditary spherocytosis, elliptocytosis, and other red cell membrane disorders. Blood Rev. 2013;27(4):167-178.
64. Smith BD, Segel GB. Abnormal erythrocyte endothelial adherence in hereditary stomatocytosis. Blood. 1997;89(9):3451-3456.
65. Janeway CA Jr, Travers P, Walport M, et al. Immunobiology: The Immune System in Health and Disease. New York: Garland Science; 2001.
66. Champion JA, Mitragotri S. Role of target geometry in phagocytosis. Proc Natl Acad Sci USA. 2006;103(13):4930-4934.
67. deCathelineau AM, Henson PM. The final step in programmed cell death: phagocytes carry apoptotic cells to the grave. Essays Biochem. 2003;39:105-117.
68. Erwig LP, Henson PM. Clearance of apoptotic cells by phagocytes. Cell Death Differ. 2008;15(2):243-250.
69. Allen LA, Aderem A. Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages. J Exp Med. 1996;184(2):627-637.
70. Malorni W, Straface E, Pagano G, et al. Cytoskeleton alterations of erythrocytes from patients with Fanconi's anemia. FEBS Lett. 2000;468(2-3):125-128.
71. Swanson JA, Johnson MT, Beningo K, Post P, Mooseker M, Araki N. A contractile activity that closes phagosomes in macrophages. J Cell Sci. 1999;112(Pt 3):307-316.
72. Subramanian S, Parthasarathy R, Sen S, Boder ET, Discher DE. Species- and cell type-specific interactions between CD47 and human SIRPalpha. Blood. 2006;107(6):2548-2556.
73. Takenaka K, Prasolava TK, Wang JCY, et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol. 2007;8(12):1313-1323.
74. Anniss AM, Sparrow RL. Expression of CD47 (integrin-associated protein) decreases on red blood cells during storage. Transfus Apheresis Sci. 2002;27(3):233-238.
75. Kamel N, Goubran F, Ramsis N, Ahmed AS. Effects of storage time and leucocyte burden of packed and buffy-coat depleted red blood cell units on red cell storage lesion. Blood Transfus. 2010;8(4):260-266.
76. Stewart A, Urbaniak S, Turner M, Bessos H. The application of a new quantitative assay for the monitoring of integrin-associated protein CD47 on red blood cells during storage and comparison with the expression of CD47 and phosphatidylserine with flow cytometry. Transfusion. 2005;45(9):1496-1503.
77. Olsson M, Oldenborg PA. CD47 on experimentally senescent murine RBCs inhibits phagocytosis following Fcgamma receptor-mediated but not scavenger receptor-mediated recognition by macrophages. Blood. 2008;112(10):4259-4267.
78. Burger P, Hilarius-Stokman P, de Korte D, van den Berg TK, van Bruggen R. CD47 functions as a molecular switch for erythrocyte phagocytosis. Blood. 2012;119(23):5512-5521.